N/A
N=60
DDEP for Lifestyle Modification in Chronic Kidney Disease
Chronic Kidney Diseases
Bottom Line
View on ClinicalTrials.gov: NCT06226649 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Change From Baseline in eGFR at 3 Months (Patient-specific) — -1.71; -4.12 ml/min/1.73m^2
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Digital Dyadic Empowerment (Behavioral)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- National Cheng Kung University
- Primary completion
- Nov 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in eGFR at 3 Months (Patient-specific) |
-1.71; -4.12 | — |
| PRIMARY Change From Baseline in CKD Stage at 3 Months (Patient-specific) |
2; 4; 18; 20; 6; 5 | — |
| PRIMARY Change From Baseline in TTM Stage at 3 Months |
4; 5; 14; 19; 8; 5 | — |
| PRIMARY Change From Baseline in Health Promoting Lifestyle at 3 Months (Patient-specific) |
5.96; -8.17 | — |
| PRIMARY Change From Baseline in Quality of Life at 3 Months |
-0.02; -0.16 | — |
| SECONDARY Change From Baseline in Adherence to Health Behaviors at 3 Months (Patient-specific) |
1.81; 0.10 | — |
| SECONDARY Change From Baseline in Helping Relationships From Significant Others at 3 Months (Patient-specific) |
4.42; -8.86 | — |
| SECONDARY Change From Baseline in Dyadic Adjustment at 3 Months |
2.49; -1.47 | — |
Summary
This is a randomized controlled feasibility trial conducted on patients with Chronic Kidney Disease (CKD) and their significant other
Eligibility Criteria
Inclusion Criteria
- The patient has a diagnosis of Chronic Kidney Disease for at least six months;
- The patient can identify a helpful significant other and both parties are willing to participate;
- The patient can communicate in Mandarin or Taiwanese.
Exclusion Criteria
- The significant other is a healthcare provider;
- The patient or the significant other has a mental illness diagnosis;
- The patient is currently receiving renal replacement therapies.
Data sourced from ClinicalTrials.gov (NCT06226649). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.